Olema Pharmaceuticals(OLMA) - 2023 Q4 - Annual Results

Olema Pharmaceuticals, Inc. Form 8-K Current Report Item 2.02 Results of Operations and Financial Condition Olema Pharmaceuticals, Inc. announced its fiscal year 2023 financial results on March 11, 2024, furnished via Exhibit 99.1 - The company reported its financial results for the year ended December 31, 2023, via a press release[6] - The press release with financial results is attached as Exhibit 99.1 and incorporated by reference[6] - Information in this section and Exhibit 99.1 is furnished, not filed, limiting legal liabilities under Section 18 of the Securities Exchange Act of 1934[7] Item 9.01 Financial Statements and Exhibits This section details the exhibits accompanying the Form 8-K, including the financial results press release and interactive data file List of Exhibits | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press Release, dated March 11, 2024, of Olema Pharmaceuticals, Inc. | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | Signatures The report was duly authorized and signed by Shane Kovacs, Chief Operating and Financial Officer, on March 11, 2024 - The report was signed on behalf of the registrant by Shane Kovacs, Chief Operating and Financial Officer[11][13]